The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections

In 1996, the Board of Directors of the American Cancer Society (ACS) challenged the United States to reduce what looked to be possible peak cancer mortality in 1990 by 50% by the year 2015. This analysis examines the trends in cancer mortality across this 25‐year challenge period from 1990 to 2015. In 2015, cancer death rates were 26% lower than in 1990 (32% lower among men and 22% lower among women). The 50% reduction goal was more fully met for the cancer sites for which there was enactment of effective approaches for prevention, early detection, and/or treatment. Among men, mortality rates dropped for lung cancer by 45%, for colorectal cancer by 47%, and for prostate cancer by 53%. Among women, mortality rates dropped for lung cancer by 8%, for colorectal cancer by 44%, and for breast cancer by 39%. Declines in the death rates of all other cancer sites were substantially smaller (13% among men and 17% among women). The major factors that accounted for these favorable trends were progress in tobacco control and improvements in early detection and treatment. As we embark on new national cancer goals, this recent past experience should teach us that curing the cancer problem will require 2 sets of actions: making new discoveries in cancer therapeutics and more completely applying those discoveries in cancer prevention we have already made. CA Cancer J Clin 2016;66:359–369. © 2016 American Cancer Society.

[1]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[2]  Douglas K Owens,et al.  Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[3]  Kassandra I. Alcaraz,et al.  Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities , 2016, CA: a cancer journal for clinicians.

[4]  Moon S. Chen,et al.  Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females , 2016, CA: a cancer journal for clinicians.

[5]  M. Shiffman Universal screening for chronic hepatitis C virus , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[6]  Z. Kos,et al.  Biomarker assessment and molecular testing for prognostication in breast cancer , 2016, Histopathology.

[7]  J. Ward,et al.  Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs. , 2015, The New England journal of medicine.

[8]  J. Foulds Use of Electronic Cigarettes by Adolescents. , 2015, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[9]  A. Jemal,et al.  Association Between the Affordable Care Act Dependent Coverage Expansion and Cervical Cancer Stage and Treatment in Young Women. , 2015, JAMA.

[10]  Christopher P. Wild,et al.  Genomics of Cancer and a New Era for Cancer Prevention , 2015, PLoS genetics.

[11]  A. Jemal,et al.  Elimination of cost‐sharing and receipt of screening for colorectal and breast cancer , 2015, Cancer.

[12]  A. Jemal,et al.  Where Can Colorectal Cancer Screening Interventions Have the Most Impact? , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[13]  Brian A. King,et al.  Tobacco Use Among Middle and High School Students — United States, 2011–2014 , 2015, MMWR. Morbidity and mortality weekly report.

[14]  T. Bethea,et al.  Health Disparities and Cancer: Racial Disparities in Cancer Mortality in the United States, 2000–2010 , 2015, Front. Public Health.

[15]  J. Dillner Prevention of human papillomavirus-associated cancers. , 2015, Seminars in oncology.

[16]  P. Klenerman,et al.  Hepatitis C , 2015, The Lancet.

[17]  A. Schuchat HPV "coverage". , 2015, The New England journal of medicine.

[18]  S. Soumerai,et al.  Mammography rates 3 years after the 2009 US Preventive Services Task Force Guidelines changes. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  G. Anderson,et al.  Menopausal hormone therapy and breast cancer mortality: clinical implications , 2015, Therapeutic advances in drug safety.

[20]  G. Andriole,et al.  Aspirin, NSAIDs, and Risk of Prostate Cancer: Results from the REDUCE Study , 2014, Clinical Cancer Research.

[21]  G. Silvestri,et al.  Master Settlement Agreement (MSA) Spending and Tobacco Control Efforts , 2014, PloS one.

[22]  A. Jemal,et al.  Dependent coverage and use of preventive care under the Affordable Care Act. , 2014, The New England journal of medicine.

[23]  S. Lagarde No one left behind: the road to 80% by 2018. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  G. Hortobagyi,et al.  Past, present, and future challenges in breast cancer treatment. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[26]  Ahmedin Jemal,et al.  Childhood and adolescent cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[27]  K. Flegal,et al.  Prevalence of childhood and adult obesity in the United States, 2011-2012. , 2014, JAMA.

[28]  G. L. Gabor Miklos,et al.  Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection. , 2013, Journal of the National Cancer Institute.

[29]  V. Moyer,et al.  Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement , 2013, Annals of Internal Medicine.

[30]  O. Brawley Health disparities in breast cancer. , 2013, Obstetrics and gynecology clinics of North America.

[31]  Ian M Thompson,et al.  Long-term survival of participants in the prostate cancer prevention trial. , 2013, The New England journal of medicine.

[32]  G. Colditz,et al.  Online Continuing Education Activity Article Title: American Cancer Society Lung Cancer Screening Guidelines Continuing Medical Education Accreditation and Designation Statement: Continuing Nursing Education Accreditation and Designation Statement: Educational Objectives: Activity Disclosures Acs Co , 2022 .

[33]  A. Trentham-Dietz,et al.  A Sustained Decline in Postmenopausal Hormone Use: Results From the National Health and Nutrition Examination Survey, 1999–2010 , 2012, Obstetrics and gynecology.

[34]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[35]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[36]  B. G. Blijenberg,et al.  Prostate-cancer mortality at 11 years of follow-up. , 2012, The New England journal of medicine.

[37]  Mary C. White,et al.  Cancer screening - United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.

[38]  J. Gohagan,et al.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. , 2012, Journal of the National Cancer Institute.

[39]  Eva Negri,et al.  Pancreatic cancer: Overview of descriptive epidemiology , 2012, Molecular carcinogenesis.

[40]  T. Byers,et al.  Does intentional weight loss reduce cancer risk? , 2011, Diabetes, obesity & metabolism.

[41]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[42]  C. Klabunde,et al.  Trends in Colorectal Cancer Test Use among Vulnerable Populations in the United States , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[43]  Xu Xi,et al.  To Be American , 2011, Fourth Genre: Explorations in Nonfiction.

[44]  M. Gilbert,et al.  Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  T. Julian,et al.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. , 2010, The Lancet. Oncology.

[46]  A. D'Amico,et al.  American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.

[47]  L. Seeff,et al.  Increase in Screening for Colorectal Cancer in Older Americans: Results from a National Survey , 2008, Journal of the American Geriatrics Society.

[48]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[49]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[50]  G. Giovino,et al.  The tobacco epidemic in the United States. , 2007, American journal of preventive medicine.

[51]  Charles Wiggins,et al.  Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. , 2007, Cancer.

[52]  E. Feuer,et al.  Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey , 2007, Cancer.

[53]  Tim Byers,et al.  A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015 , 2006, Cancer.

[54]  Norman Wolmark,et al.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. , 2006, JAMA.

[55]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[56]  David K. Espey,et al.  Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990–2001 , 2005, Cancer.

[57]  K. Arnold Setting goals for cancer mortality: earlier initiatives offer lessons for the future. , 2003, Journal of the National Cancer Institute.

[58]  M. Cowen,et al.  The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. , 2003, Archives of internal medicine.

[59]  F. Gilliland,et al.  Effects of misattribution in assigning cause of death on prostate cancer mortality rates. , 2003, Annals of epidemiology.

[60]  Nancy Breen,et al.  Progress in cancer screening practices in the United States , 2003, Cancer.

[61]  L. Abenhaim [Progress against cancer!]. , 2003, Revue d'epidemiologie et de sante publique.

[62]  俊郎 黒木,et al.  Centers for Disease Control and Prevention (CDC) ホームページの活用法 , 2002 .

[63]  C. Sawyers,et al.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.

[64]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[65]  T. Byers,et al.  The American Cancer Society challenge goals , 1999, Cancer.

[66]  Edoardo Cervoni,et al.  Hepatitis C , 1998, The Lancet.

[67]  E. Powell-Griner,et al.  State-and sex-specific prevalence of selected characteristics--behavioral risk factor surveillance system, 1994 and 1995. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[68]  L. Brammer,et al.  Influenza surveillance--United States, 1992-93 and 1993-94. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[69]  C. Okoro,et al.  State- and sex-specific prevalence of selected characteristics--Behavioral Risk Factor Surveillance System, 1992 and 1993. , 1996, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[70]  D. May,et al.  Has the use of cervical, breast, and colorectal cancer screening increased in the United States? , 1995, American journal of public health.

[71]  H. Mukhtar,et al.  International Agency for Cancer Research, IARC Monographs on the evaluation of carcinogenic risks to humans , IARC, World Health Organization, Lyon, France (1992) 316 pages. 65 Swiss francs. , 1994 .

[72]  T. Allen-Mersh,et al.  Cancer Control Objectives for the Nation: 1985–2000: NCI Monographs No. 2 , 1987 .

[73]  D. Mccormick Sequence the Human Genome , 1986, Bio/Technology.

[74]  J. Bailar,et al.  Progress against cancer? , 1986, The New England journal of medicine.

[75]  A. Jemal,et al.  Breast cancer statistics, 2015: Convergence of incidence rates between black and white women , 2016, CA: a cancer journal for clinicians.

[76]  F. Speizer,et al.  Smoking and Mortality - Beyond Established Causes. , 2016, The New England journal of medicine.

[77]  R. Schilsky,et al.  Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  C. Lawton,et al.  Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) , 2012 .

[79]  L. Shulman The Decrease in Breast-Cancer Incidence in 2003 in the United States , 2008 .

[80]  A. V. von Eschenbach,et al.  NCI sets goal of eliminating suffering and death due to cancer by 2015. , 2003, Journal of the National Medical Association.

[81]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[82]  M. Carroll,et al.  Overweight and obesity in the United States: prevalence and trends, 1960–1994 , 1998, International Journal of Obesity.

[83]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.